Chengdu Novi Biomedical Co., Ltd.

Development of biotechnology and pharmaceutical technology (excluding pre-licensing projects, post-licensing projects are operated with licenses or approval documents); production of chemical products (excluding hazardous chemicals) (industrial industries set up branches or choose other business locations for operation) and technology research and development, technology transfer; quality inspection and technical services (excluding import and export commodity inspection and appraisal, excluding the design, manufacture, installation and non-destructive testing of civil nuclear safety equipment, and excluding special equipment inspection and testing); sales of chemical products (excluding hazardous chemicals) and instruments. (Projects that must be approved according to law can only be carried out after approval by relevant departments).
Business Type Manufacturer
Location ChinaSichuanChengdu
Year Established 2013-05-06
Total Employees 25
Total Annual Revenue -
Main Products 2,3-pyrazinedicarboxylic acid, 2-chloromethyl-4-methylquinazoline, 3-nitrophthalic acid, D-mannitol, folic acid, p-fluoronitrobenzene, p-aminobenzenesulfonic acid, labetalol, posaconazole, mannose, valsartan, cytidine, simvastatin, azilsartan medoxomil
Main Market -